ES2709298B2 - Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento - Google Patents

Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento Download PDF

Info

Publication number
ES2709298B2
ES2709298B2 ES201731210A ES201731210A ES2709298B2 ES 2709298 B2 ES2709298 B2 ES 2709298B2 ES 201731210 A ES201731210 A ES 201731210A ES 201731210 A ES201731210 A ES 201731210A ES 2709298 B2 ES2709298 B2 ES 2709298B2
Authority
ES
Spain
Prior art keywords
procedure
methyl
piridin
benzodiazepin
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201731210A
Other languages
English (en)
Other versions
ES2709298A1 (es
Inventor
Casals Carles Sanchez
Rodriguez Alicia Dobarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Moehs Iberica SL
Original Assignee
Moehs Iberica SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moehs Iberica SL filed Critical Moehs Iberica SL
Priority to ES201731210A priority Critical patent/ES2709298B2/es
Priority to US16/754,821 priority patent/US11325911B2/en
Priority to EP18788710.4A priority patent/EP3694859A1/en
Priority to PCT/EP2018/077669 priority patent/WO2019072944A1/en
Publication of ES2709298A1 publication Critical patent/ES2709298A1/es
Application granted granted Critical
Publication of ES2709298B2 publication Critical patent/ES2709298B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES201731210A 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento Active ES2709298B2 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES201731210A ES2709298B2 (es) 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
US16/754,821 US11325911B2 (en) 2017-10-13 2018-10-11 Method for preparing 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[ 1,2-a][1,4]benzodiazepin-4-yl]-propionic acid methyl ester, and compounds useful in said method
EP18788710.4A EP3694859A1 (en) 2017-10-13 2018-10-11 Method for preparing 3-[(4s)-8-bromo-1-methyl-6-(pyridin-2-yl)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-yl]-propionic acid methyl ester, and compounds useful in said method
PCT/EP2018/077669 WO2019072944A1 (en) 2017-10-13 2018-10-11 PROCESS FOR THE PREPARATION OF 3 - [(4S) -8-BROMO-1-METHYL-6- (PYRIDIN-2-YL) -4H-IMIDAZO [1,2-A] [1,4] METHYL ESTER METHYL ESTER BENZODIAZEPIN-4-YL] -PROPIONIC AND COMPOUNDS USEFUL IN SAID PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201731210A ES2709298B2 (es) 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento

Publications (2)

Publication Number Publication Date
ES2709298A1 ES2709298A1 (es) 2019-04-15
ES2709298B2 true ES2709298B2 (es) 2019-08-21

Family

ID=63878652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201731210A Active ES2709298B2 (es) 2017-10-13 2017-10-13 Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento

Country Status (4)

Country Link
US (1) US11325911B2 (es)
EP (1) EP3694859A1 (es)
ES (1) ES2709298B2 (es)
WO (1) WO2019072944A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3580219B1 (en) * 2017-02-09 2022-04-13 Assia Chemical Industries Ltd. Process for the preparation of remimazolam and solid state forms of remimazolam salts
ES2697918A1 (es) * 2017-07-28 2019-01-29 Moehs Iberica Sl Procedimiento para preparar ester metilico del acido 3-[(3s)-7-bromo-2-oxo-5-(piridin-2-il)-2,3-dihidro-1h-[1,4]-benzodiazepin-3-il] propionico, y compuestos utiles en ese procedimiento
ES2709298B2 (es) 2017-10-13 2019-08-21 Moehs Iberica Sl Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
ES2803099B2 (es) 2019-07-22 2021-11-08 Moehs Iberica Sl Procedimiento de obtención de besilato de remimazolam amorfo
ES2827125A1 (es) * 2019-11-19 2021-05-19 Moehs Iberica Sl Intermedio util en la preparacion de remimazolam, su procedimiento de obtencion, y su uso en la obtencion de remimazolam
CN114644612B (zh) * 2020-12-17 2023-04-28 成都苑东生物制药股份有限公司 一种苯二氮杂类神经抑制剂中间体化合物的制备方法
CN114014839A (zh) * 2021-12-16 2022-02-08 上海再启生物技术有限公司 一种制备瑞马唑仑关键中间体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001261A (en) 1975-10-20 1977-01-04 The Upjohn Company Process for the production of 1-[(dimethylamino)methyl]-6-phenyl-4H-imidazo[1,2-a][1,4]-benzodiazepine
GB9911152D0 (en) 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
EP2305647A1 (en) * 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
AR094963A1 (es) * 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
EP3580219B1 (en) * 2017-02-09 2022-04-13 Assia Chemical Industries Ltd. Process for the preparation of remimazolam and solid state forms of remimazolam salts
ES2697918A1 (es) * 2017-07-28 2019-01-29 Moehs Iberica Sl Procedimiento para preparar ester metilico del acido 3-[(3s)-7-bromo-2-oxo-5-(piridin-2-il)-2,3-dihidro-1h-[1,4]-benzodiazepin-3-il] propionico, y compuestos utiles en ese procedimiento
ES2709298B2 (es) 2017-10-13 2019-08-21 Moehs Iberica Sl Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento

Also Published As

Publication number Publication date
EP3694859A1 (en) 2020-08-19
US20200239477A1 (en) 2020-07-30
WO2019072944A1 (en) 2019-04-18
US11325911B2 (en) 2022-05-10
ES2709298A1 (es) 2019-04-15

Similar Documents

Publication Publication Date Title
ES2709298B2 (es) Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
IL247949A0 (en) New histories of pyrazolopyrimidines and their use as malt1 inhibitors
BR112016000937A2 (pt) formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
PT3258962T (pt) Composições mistas de alergénios e métodos para a utilização das mesmas
PL3271413T3 (pl) Kwasy estryfikowane do stosowania w materiałach polimerowych
ES2970186T3 (es) Formulaciones farmacéuticas y métodos de uso de las mismas
EP2941130A4 (en) MULTI-PURPOSE INGREDIENT FOR BAKERY PRODUCTS AND OTHER PRODUCTS
LT2964215T (lt) Riebalų rūgščių mišinys, skirtas naudoti uždegiminių patologijų gydymui
SG11201803022TA (en) Compositions comprising fatty acids and their use
IL250271A0 (en) A mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
HK1250161B (zh) 6-嗎啉基-2-吡唑基-9h-嘌呤衍生物及其作為pi3k抑制劑的用途
EP2987786A4 (en) AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE
HK1254896A1 (zh) 鯨蠟脂肪酸、其製備系統及其應用
EP3466534A4 (en) SOLID CATALYST FOR THE PREPARATION OF METHYL OR ETHYL ESTER OF FATTY ACID AND PROCESS FOR PREPARING METHYL OR ETHYL ESTER OF FAT ACID USING SAME
ES2523418R2 (es) Procedimiento de obtencion de composiciones protegidas para alimentacion animal, composiciones y uso de las mismas
EP2948751A4 (en) METHOD AND DEVICE FOR THE ANALYSIS OF FATTY ACIDS
EP3305757A4 (en) 10-HYDROXY-CIS-12-OCTADECENIC ACID ELISA AND USE THEREOF
HK1249442A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP2981636A4 (en) IMPROVED NEUTRALIZATION AND REMOVAL OF ACIDS IN HVAC SYSTEMS BY USING DRYING AGENTS
PL3262047T3 (pl) Pochodne imidazopirymidyny i imidazotriazyny i kompozycje farmaceutyczne je zawierające
HK1249440A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
PT3177283T (pt) Composto ativo e composição relacionada pata utilização dermatológica no campo farmacêutico ou cosmético
CO7000749A2 (es) Método y programa de compuradora para monitorear el uso de un producto absorbente
EP3532583C0 (en) GLYCEROL ETHOXYLATE AS AN ACTIVE INGREDIENT TO REMOVE MAKEUP STAINS
HK1249441A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2709298

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20190415

FG2A Definitive protection

Ref document number: 2709298

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20190821